These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19710979)

  • 1. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.
    Chow LC; Lee BS; Tang SO; Loh EW; Ng SC; Tan XY; Ahmad Noordin MN; Ong GB; Chew LC
    Med J Malaysia; 2024 May; 79(3):281-287. PubMed ID: 38817060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study.
    Chun GY; Ng SSM; Islahudin F; Selvaratnam V; Mohd Tahir NA
    Int J Clin Pharm; 2024 Jun; 46(3):736-744. PubMed ID: 38551751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
    Chapin J; Cohen AR; Neufeld EJ; Vichinsky E; Giardina PJ; Boudreaux J; Le BC; Kenney K; Trimble S; Thompson AA
    Br J Haematol; 2022 Jan; 196(2):380-389. PubMed ID: 34775608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of luspatercept therapy in patients with transfusion-dependent β-thalassaemia.
    Sheth S; Taher AT; Coates TD; Kattamis A; Cappellini MD
    Br J Haematol; 2023 Jun; 201(5):824-831. PubMed ID: 37037668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Related to the Quality of Life in Children with Transfusion-Dependent Thalassemia.
    Permana DA; Susanah S; Adrizain R; Rahayuningsih SE; Dhamayanti M; Rakhmilla LE
    Pediatr Hematol Oncol; 2024 Apr; 41(3):179-197. PubMed ID: 38424668
    [No Abstract]   [Full Text] [Related]  

  • 7. Addressing Thalassaemia Management from Patients' Perspectives: An International Collaborative Assessment.
    Economidou EC; Angastiniotis M; Avraam D; Soteriades ES; Eleftheriou A
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674296
    [No Abstract]   [Full Text] [Related]  

  • 8. Expenditure to treat thalassaemia: an experience at a tertiary care hospital in India.
    Mallik S; Chatterjee C; Mandal PK; Sardar JC; Ghosh P; Manna N
    Iran J Public Health; 2010; 39(1):78-84. PubMed ID: 23112993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalassaemia: NHS to offer stem cell transplants to adults who need transfusions.
    Kmietowicz Z
    BMJ; 2023 Nov; 383():2837. PubMed ID: 38030406
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlates of splenic T2* measurements in transfusion-dependent thalassaemia and comparison between non-splenectomised and splenectomised patients.
    Meloni A; Pistoia L; Positano V; Spasiano A; Putti MC; Fotzi I; Corigliano E; Cossu A; Massa A; Massei F; Alberini G; Cademartiri F
    Br J Haematol; 2023 Nov; 203(3):e93-e97. PubMed ID: 37559348
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of health state utility values using SF-6D for Chinese adult patients with β-thalassemia major.
    Zhang R; Zhang S; Ming J; Xie J; Liu B; Chen C; Sun X; Zhen X
    Front Public Health; 2022; 10():1072866. PubMed ID: 36743186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.
    Rodigari F; Brugnera G; Colombatti R
    Front Pediatr; 2022; 10():886674. PubMed ID: 36090573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment.
    Shafie AA; Chhabra IK; Wong JHY; Mohammed NS
    Health Qual Life Outcomes; 2021 Jan; 19(1):10. PubMed ID: 33413416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry.
    Mohd Ibrahim H; Muda Z; Othman IS; Mohamed Unni MN; Teh KH; Thevarajah A; Gunasagaran K; Ong GB; Yeoh SL; Muhammad Rivai A; Che Mohd Razali CH; Din ND; Abdul Latiff Z; Jamal R; Mohamad N; Mohd Ariffin H; Alias H
    BMJ Open; 2020 Jun; 10(6):e037974. PubMed ID: 32601117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in transfusion-dependent thalassemia patients.
    Alzahrani RA; Almutairi OM; Alghoraibi MS; Alabdulwahed MS; Abaalkhail MK; Alhawish MK; Alosaimy MT
    J Taibah Univ Med Sci; 2017 Oct; 12(5):465-470. PubMed ID: 31435280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.
    Cappellini MD; Porter J; Origa R; Forni GL; Voskaridou E; Galactéros F; Taher AT; Arlet JB; Ribeil JA; Garbowski M; Graziadei G; Brouzes C; Semeraro M; Laadem A; Miteva D; Zou J; Sung V; Zinger T; Attie KM; Hermine O
    Haematologica; 2019 Mar; 104(3):477-484. PubMed ID: 30337358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life (HRQoL) in beta-thalassemia major (β-TM) patients assessed by 36-item short form health survey (SF-36): a meta-analysis.
    Arian M; Mirmohammadkhani M; Ghorbani R; Soleimani M
    Qual Life Res; 2019 Feb; 28(2):321-334. PubMed ID: 30194626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting quality of life in children and adolescents with thalassemia in Iraqi Kurdistan.
    Mikael NA; Al-Allawi NA
    Saudi Med J; 2018 Aug; 39(8):799-807. PubMed ID: 30106418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life (QoL) and the Factors Affecting it in Transfusion-dependent Thalassemic Children.
    Chordiya K; Katewa V; Sharma P; Deopa B; Katewa S
    Indian J Pediatr; 2018 Nov; 85(11):978-983. PubMed ID: 29752583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.
    Seyedifar M; Dorkoosh FA; Hamidieh AA; Naderi M; Karami H; Karimi M; Fadaiyrayeny M; Musavi M; Safaei S; Ahmadian-Attari MM; Hadjibabaie M; Cheraghali AM; Akbari Sari A
    Int J Hematol Oncol Stem Cell Res; 2016 Oct; 10(4):224-231. PubMed ID: 27928477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.